ArticleJournal of fluorescence2025
Synthesis, Computational, DFT Calculations, Photophysical and Docking Studies of Novel Fluorescent Pyrimidine-Chlorothymol Hybrid as Potent Antimicrobial Agent.
Article in Journal of fluorescence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Molecular fluorescent probes have found numerous applications in material science and biology. Fluorescently labelled heterocyclic compounds are found usage in light-emitting diodes, high throughput screening, bioanalytical applications, and diagnostics. Hence, this study focuses on the synthesis of a novel functionalized 4-((6-chloro-2-(trifluoromethyl)pyrimidin-4-yl)amino)-2-isopropyl-5-methyl phenol (CTPP) molecule using molecular hybridization approach as an antimicrobial agent and fluorescent probe. The synthesized CTPP molecule was characterized utilizing various spectroscopic techniques. The synthesized CTPP molecule was validated for their antimicrobial studies. With MIC values of 11.8 ± 0.26 and 14.6 ± 0.35 µM against S. aureus and C. albicans strains, respectively, the CTPP molecule significantly surpassed the reference medications streptomycin and fluconazole. The molecular docking results revealed that CTPP molecules has shown favourable binding interactions with good binding site energies against the target 3VO8 and 7PJC proteins. Computational studies were performed using the DFT method with a B3LYP/6-311G basis set used to explore the molecular geometry, global reactive descriptors, MEP, absorption, emission, ELF, LOL, RDG and NLO characteristics. It was discovered that the CTPP molecule's calculated NLO values were superior to reference molecule urea in both the gas and solvent phases. Moreover, the first and second hyperpolarizability values for CTPP molecule in gas and DMSO phase indicate that they could be employed as good nonlinear optical materials. The results of both theoretical and experimental research demonstrate that the CTPP molecule is a promising one that can be applied to NLO-based products in the optoelectronic industry.
Indexed as
Identifiers
40153236What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.